Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor

被引：0
|
作者：
Dee, Edward Christopher [1 ]
Freret, Morgan E. [2 ]
Wo, Jennifer Y. [1 ,3 ]
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / Suppl 3期
关键词：
CHEMOTHERAPY; GEMCITABINE; TRIAL;
D O I：
10.1245/s10434-020-09130-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：937 / 939
页数：3
相关论文
共 50 条
  • [1] Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor
    Edward Christopher Dee
    Morgan E. Freret
    Jennifer Y. Wo
    Annals of Surgical Oncology, 2020, 27 : 937 - 939
  • [2] ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers
    Edward Christopher Dee
    Morgan E. Freret
    Jennifer Y. Wo
    Annals of Surgical Oncology, 2020, 27 : 5173 - 5174
  • [3] ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers
    Dee, Edward Christopher
    Freret, Morgan E.
    Wo, Jennifer Y.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 5173 - 5174
  • [4] Do Any Subgroups of Resected Biliary Tract Cancers Patients That Benefit the Most from Adjuvant Chemoradiation Therapy?
    Ma, Wen-Jie
    Zhou, Rong-Xing
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 934 - 936
  • [5] Do Any Subgroups of Resected Biliary Tract Cancers Patients That Benefit the Most from Adjuvant Chemoradiation Therapy?
    Wen-Jie Ma
    Rong-Xing Zhou
    Annals of Surgical Oncology, 2020, 27 : 934 - 936
  • [6] Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation
    Shulman, Rebecca M.
    Meyer, Joshua E.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 4867 - 4869
  • [7] Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation
    Edward Christopher Dee
    Morgan E. Freret
    Nora Horick
    Ann C. Raldow
    Lipika Goyal
    Andrew X. Zhu
    Aparna R. Parikh
    David P. Ryan
    Jeffrey W. Clark
    Jill N. Allen
    Cristina R. Ferrone
    Carlos Fernandez-del Castillo
    Kenneth K. Tanabe
    Lorraine C. Drapek
    Theodore S. Hong
    Motaz Qadan
    Jennifer Y. Wo
    Annals of Surgical Oncology, 2020, 27 : 5161 - 5172
  • [8] Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation
    Dee, Edward Christopher
    Freret, Morgan E.
    Horick, Nora
    Raldow, Ann C.
    Goyal, Lipika
    Zhu, Andrew X.
    Parikh, Aparna R.
    Ryan, David P.
    Clark, Jeffrey W.
    Allen, Jill N.
    Ferrone, Cristina R.
    Fernandez-del Castillo, Carlos
    Tanabe, Kenneth K.
    Drapek, Lorraine C.
    Hong, Theodore S.
    Qadan, Motaz
    Wo, Jennifer Y.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 5161 - 5172
  • [9] Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation
    Rebecca M. Shulman
    Joshua E. Meyer
    Annals of Surgical Oncology, 2020, 27 : 4867 - 4869
  • [10] Fluoropyrimidine-based adjuvant chemotherapy in patients with resected biliary tract cancers.
    Go, Se-il
    Kang, Jung Hun
    Jeong, Chi-Young
    Lee, Gyeong-won
    Kim, Hoon-Gu
    Kang, Myoung-Hee
    Song, Haa-na
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345